Evidence map›Paper›PMID 40607290›Full record

ArticleAnnals of gastroenterological surgery2025

Clinical significance of preoperative Glasgow prognostic score in patients with colorectal cancer and synchronous peritoneal metastases.

Kosuke Fujimoto, Fumikazu Koyama, Hirotoshi Kobayashi, Kenjiro Kotake, Masayasu Kawasaki, Yukihide Kanemitsu, Yusuke Kinugasa, Hideki Ueno, Kotaro Maeda, Takeshi Suto and 22 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of gastroenterological surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Kosuke FujimotoDepartment of Surgery Nara Medical University Kashihara Japan.
Fumikazu KoyamaDepartment of Surgery Nara Medical University Kashihara Japan.ORCID https://orcid.org/0000-0002-2775-908X
Hirotoshi KobayashiDepartment of Surgery Tokyo Metropolitan Hiroo Hospital Tokyo Japan.ORCID https://orcid.org/0000-0002-4381-0439
Kenjiro KotakeDepartment of Surgery Sano City Hospital Tochigi Japan.
Masayasu KawasakiDepartment of Surgery Bell Land General Hospital Sakai Japan.ORCID https://orcid.org/0000-0002-9306-493X
Yukihide KanemitsuDepartment of Colorectal Surgery National Cancer Center Hospital Tokyo Japan.
Yusuke KinugasaDepartment of Gastrointestinal Surgery Tokyo Medical and Dental University Tokyo Japan.ORCID https://orcid.org/0000-0002-7885-2276
Hideki UenoDepartment of Surgery National Defense Medical College Tokorozawa Japan.ORCID https://orcid.org/0000-0002-8600-1199
Kotaro MaedaInternational Medical Center Fujita Health University Hospital Toyoake Japan.
Takeshi SutoDepartment of Gastroenterological Surgery Yamagata Prefectural Central Hospital Yamagata Japan.
Michio ItabashiDepartment of Surgery, Institute of Gastroenterology Tokyo Women's Medical University Tokyo Japan.
Kimihiko FunahashiDepartment of General and Gastroenterological Surgery Toho University Omori Medical Center Tokyo Japan.
Heita OzawaDepartment of Surgery Tochigi Cancer Center Utsunomiya Japan.
Shingo NouraDepartment of Surgery Osaka Rosai Hospital Sakai Japan.
Hideyuki IshidaDepartment of Digestive Tract and General Surgery, Saitama Medical Center Saitama Medical University Kawagoe Japan.
Masayuki OhueDepartment of Gastroenterological Surgery Osaka International Cancer Institute Osaka Japan.
Tomomichi KiyomatsuDepartment of Colorectal Surgery National Center for Global Health and Medicine Tokyo Japan.
Soichiro IshiharaDepartment of Surgical Oncology The University of Tokyo Hospital Tokyo Japan.
Keiji KodaDepartment of Surgery Teikyo University Chiba Medical Center Ichihara Japan.
Hideo BabaDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.ORCID https://orcid.org/0000-0002-3474-2550
Kenji KawadaDepartment of Gastrointestinal Surgery, Graduate School of Medicine Kyoto University Kyoto Japan.ORCID https://orcid.org/0000-0003-4336-6937
Yojiro HashiguchiDepartment of Surgery Teikyo University School of Medicine Tokyo Japan.
Takanori GoiFirst Department of Surgery University of Fukui Fukui Japan.
Yuji ToiyamaDepartment of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences Mie University Graduate School of Medicine Tsu Mie Japan.ORCID https://orcid.org/0000-0003-1301-3268
Naohiro TomitaDivision of Lower Gastrointestinal Surgery, Department of Gastroenterological Surgery Hyogo Medical University Nishinomiya Hyogo Japan.
Eiji SunamiDepartment of Surgery Kyorin University School of Medicine Tokyo Japan.
Fumihiko FujitaDepartment of Surgery Kurume University School of Medicine Kurume Japan.
Jun WatanabeDepartment of Surgery, Gastroenterological Center Yokohama City University Medical Center Yokohama Japan.ORCID https://orcid.org/0000-0002-7187-3664
Kenichi HakamadaDepartment of Gastroenterological Surgery Hirosaki University Graduate School of Medicine Aomori Japan.ORCID https://orcid.org/0000-0001-6513-1202
Goro NakayamaDepartment of Gastroenterological Surgery (Surgery II) Nagoya University Graduate School of Medicine Nagoya Japan.
Kenichi SugiharaTokyo Medical and Dental University Tokyo Japan.
Yoichi AjiokaDivision of Molecular and Diagnostic Pathology, Graduate School of Medical and Dental Sciences Niigata University Niigata Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chemotherapy is the typical choice for treating colorectal cancer with synchronous peritoneal metastases. Nonetheless, surgical resection may be chosen if the metastases are resectable. Unfortunately, there is no reliable preoperative or intraoperative prognostic indicator. This study aimed to determine the prognostic significance of the preoperative Glasgow prognostic score (GPS) in colorectal cancer patients with synchronous peritoneal metastases. Methods: We conducted a prospective study on 143 patients with colorectal cancer and concurrent peritoneal metastases. Our analysis included prognostic factors, such as the GPS, using data from the institutional observational study by the Japanese Society for Cancer of the Colon and Rectum. Results: The 3-year survival rates for the GPS0 or 1 and GPS2 groups were 32.7% and 14.3%, respectively, with a significantly worse prognosis in the GPS2 group ( Conclusions: Preoperative GPS2 is an independent poor prognostic factor in patients with colorectal cancer and synchronous peritoneal metastases, and surgical resection does not improve prognosis in patients with GPS2. Preoperative GPSs may be used as indicators for surgical resection of synchronous peritoneal metastases.

Indexed as

colorectal cancerGlasgow prognostic scoreindicatorsperitoneal metastasessurgical resection

Identifiers

PMID40607290
PMCPMC12211111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.